Because viral infections can worsen atypical hemolytic uremic syndrome (aHUS), researchers recommend testing patients for infections that are common…
Articles by Marisa Wexler, MS
About four in 10 children in Egypt who have atypical hemolytic uremic syndrome (aHUS) test positive for antibodies against…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Atypical hemolytic uremic syndrome (aHUS) that is triggered by pregnancy is similar to aHUS caused by other triggers, and…
Preventive or early treatment with Soliris (eculizumab) appears to increase the chances of a successful kidney transplant among people…
Most people with atypical hemolytic uremic syndrome (aHUS) whose disease is in remission after treatment with complement-inhibiting medications like…
Ultomiris (ravulizumab-cwvz) is safe and effective in children with atypical hemolytic uremic syndrome (aHUS), data from a Phase 3…
After unanimous votes by the boards of directors of both companies, AstraZeneca has announced it will acquire Alexion…
The specific disease-causing mutations in a person with atypical hemolytic uremic syndrome (aHUS) affect their individual risk of relapse…
Ultomiris (ravulizumab) is expected to be more cost-effective than its predecessor Soliris (eculizumab) as a treatment for atypical…